Increased occupational exposure of radiation workers is a major problem during open reduction and internal fixation (ORIF) of the hip joint, as the surgeon\'s eye lens is in close proximity to the patient and the X-ray tube. The purposes of this study were to clarify the occupational exposure of radiation workers during ORIF of the hip joint and to examine the need for radiation protection measures. The radiation exposure of radiation workers was evaluated by making an airborne dose distribution map using phantom experiments. The radiation goggles attached with a small optically stimulated luminescence dosimeter were used in clinical practice to measure the lens dose received by the surgeon, and the necessity of radiation goggles was examined. The airborne dose distribution in ORIF of the hip joint showed a wider area of high dose rate during axial fluoroscopy of the femoral neck than during posterior-anterior fluoroscopy. In axial fluoroscopy of the femoral neck, the surgeon was always in the high dose rate range of 10 µGy/min or higher, the nurses were in the dose rate range of 4 to 10 µGy/min, and the radiologic technologists were in the dose rate range of 0.5 µGy/min or lower. The maximum 3 mm dose equivalent to the surgeon per case was 0.38 mSv. In contradiction, radiation goggles were useful in ORIF because they provided approximately 60% shielding. It is advisable to work with radiation goggles to avoid cataracts.

To determine the eye lens dose (3 mm dose equivalent [Hp(3)]) received by spine surgeons during myelography and evaluate the effectiveness of radiation-protective glasses and x-ray tube system positioning in reducing radiation exposure. This study included spine surgeons who performed myelography using over- or under-table x-ray tube systems. Hp(3) was measured for each examination using a radio-photoluminescence glass dosimeter (GD-352M) mounted on radiation-protective glass. This study identified significantly high Hp(3) levels, especially in the right eye lens in spinal surgeons. The median Hp(3) values in the right eye were 524 (391-719) and 58 (42-83)μSv/examination for over- and under-table x-ray tube systems, respectively. Further, Hp(3)AK, which was obtained by dividing the cumulative air kerma from Hp(3), was 8.09 (6.69-10.21) and 5.11 (4.06-6.31)μSv mGy-1for the over- and under-table x-ray tube systems, respectively. Implementing radiation-protective glasses resulted in dose reduction rates of 54% (50%-57%) and 54% (51%-60%) for the over- and under-table x-ray tube systems, respectively. The use of radiation protection glasses significantly reduced the radiation dose in the eye lens during myelography, with the most effective measures being the combination of using radiation protection glasses and an under-table x-ray tube system.

The radiological technologists often assist patients near the X-ray area during mobile radiography. Therefore, it is expected that the lens of eye of radiological technologists is exposed to much radiation. The purposes of this study were to measure the lens dose received by radiological technologists during mobile radiography using radiation protection goggles with a personal dosimeter and a small optically stimulated luminescence dosimeter and discuss the need for radiation protection goggles and additional radiation protection measures. From October 2017 to March 2018, lens doses were measured for eight radiological technologists during mobile radiography using radiation protection goggles with a small optically stimulated luminescence dosimeter and a personal dosimeter. The maximum value of the lens dose received by radiological technologists in mobile radiography was 0.3 mSv per month with a personal dosimeter attached to the neck. The dose-reduction effect of radiation protection glasses during mobile radiography was about 45%. The radiation protection goggles are effective for reducing radiation exposure of lens of eye during mobile radiography. Since there is concern about an increase in lens dose, it is desirable to use the radiation protection goggles for reducing the lens of eye exposure.

This study aimed to determine the placement distance, number, and position of the bismuth shield for developing a lens protective device for cone-beam computed tomography (CBCT). To determine the dose reduction rate, the lens doses were measured using an anthropomorphic head phantom and a real-time dosimeter. The image quality assessment was determined by analyzing the change in the pixel value, caused by the bismuth shield, and the artifact index was calculated from the pixel value and image noise within various regions of interest in the head phantom. When the distance between the bismuth shield and the subject was increased, the image quality deteriorated less, but there was also a decrease in the lens dose reduction rate. Upon changing the number of bismuth shields from 1-ply to 2-ply, the dose reduction rate increased; however, there was a decrease in the image quality. Additionally, placing the bismuth shield outside of the subject improved the dose reduction rate without deteriorating the image quality. The optimum placement conditions of the bismuth shield were concluded as follows: positioned outside, placed 10 mm from the surface of the subject, and used a 1-ply bismuth shield. When these placement conditions were used, the lens dose reduction rate was 26.9 ± 0.36% (right-left average) for the \"bismuth shield: separate\". The protective device developed in this study will contribute to radiation dose reduction in CBCT scans.

OBJECTIVE: This study reports a sensitivity enhancement of gold-coated contact lens-type ocular in vivo dosimeters (CLODs) for low-dose measurements in computed tomography (CT).
METHODS: Monte Carlo (MC) simulations were conducted to evaluate the dose enhancement from the gold (Au) layers on the CLODs. The human eye and CLODs were modeled, and the X-ray tube voltages were defined as 80, 120, and 140 kVp. The thickness of the Au layer attached to a CLOD ranged from 100 nm to 10 μm. The thickness of the active layer ranged from 20 to 140 μm. The dose ratio between the active layer of the Au-coated CLOD and a CLOD without a layer, i.e., the dose enhancement factor (DEF), was calculated.
RESULTS: The DEFs of the first 20-μm thick active layer of the 5-μm thick Au-coated CLOD were 18.4, 19.7, 20.2 at 80, 120, and 140 kVp, respectively. The DEFs decreased as the thickness of the active layer increased. The DEFs of 100-nm to 5-μm thick Au layers increased from 1.7 to 5.4 for 120-kVp X-ray tube voltage when the thickness of the active layer was 140 μm.
CONCLUSIONS: The MC results presented a higher sensitivity of Au-coated CLODs (∼20-times higher than that of CLODs without a gold layer). Au-coated CLODs can be applied to an evaluation of very low doses (a few cGy) delivered to patients during CT imaging.

A short curtain that improves on the low versatility of existing long curtains was developed as a dedicated radiation protective device for the over-table tube fluorographic imaging units. The effect of this short curtain in preventing cataracts was then examined. First, the physician lens dose reduction rate was obtained at the position of the lens. Next, the reduction rate in the collective equivalent dose for the lens of the physician\'s eye was estimated. The results showed that lens dose reduction rates with the long curtain and the short curtain were 88.9% (literature-based value) and 17.6%, respectively, higher with the long curtain. In our hospital, the reduction rate in the collective equivalent dose for the lens of the physician\'s eye was 9.8% and 17.6% with a procedures mixture, using the long curtain where technically possible and no curtain in all other procedures, and the short curtain in all procedures, respectively, higher with the short curtain. Moreover, a best available for curtains raised the reduction rate in the collective equivalent dose for the lens of the physician\'s eye a maximum of 25.5%. By introducing the short curtain, it can be expected to have an effect in preventing cataracts in medical staff.

OBJECTIVE: In cerebral angiography, for diagnosis and interventional neuroradiology, cone-beam computed tomography (CBCT) scan is frequently performed for evaluating brain parenchyma, cerebral hemorrhage, and cerebral infarction. However, the patient\'s eye lens is more frequently exposed to excessive doses in these scans than in the previous angiography and interventional neuroradiology (INR) procedures. Hence, radioprotection for the lenses is needed. This study selects the most suitable eye lens protection material for CBCT from among nine materials by evaluating the dose reduction rate and image quality.
METHODS: To determine the dose reduction rate, the lens doses were measured using an anthropomorphic head phantom and a real-time dosimeter. For image quality assessment, the artifact index was calculated based on the pixel value and image noise within various regions of interest in a water phantom.
RESULTS: The protective materials exhibited dose reduction; however, streak artifacts were observed near the materials. The dose reduction rate and the degree of the artifact varied significantly depending on the protective material. The dose reduction rates were 14.6%, 14.2%, and 26.0% when bismuth shield: normal (bismuth shield in the shape of an eye mask), bismuth shield: separate (two separate bismuth shields), and lead goggles were used, respectively. The \"separate\" bismuth shield was found to be effective in dose reduction without lowering the image quality.
CONCLUSIONS: We found that bismuth shields and lead goggles are suitable protective devices for the optimal reduction of lens doses.

OBJECTIVE: This study aimed to (a) develop a contact lens-type ocular in vivo dosimeter (CLOD) that can be worn directly on the eye and (b) assess its dosimetric characteristics and biological stability for radiation therapy.
METHODS: The molder of a soft contact lens was directly used to create the dosimeter, which included a radiation-sensitive component - an active layer similar to a radiochromic film - to measure the delivered dose. A flatbed scanner with a reflection mode was used to measure the change in optical density due to irradiation. The sensitivity, energy, dose rate, and angular dependence were tested, and the uncertainty in determining the dose was calculated using error propagation analysis. Sequential biological stability tests, specifically, cytotoxicity and ocular irritation tests, were conducted to ensure the safe application of the CLOD to patients.
RESULTS: The dosimeter demonstrated high sensitivity in the low dose region, and the sensitivity linearly decreased with the dose. The responses obtained for the 10 and 15 MV photon beams were 1.7% and 1.9% higher compared to the 6 MV photon beam. A strong dose rate dependence was not obtained for the CLOD. Angular dependence was observed from 90° to 180° with a difference in response from 1% to 2%. The total uncertainty in error propagation analysis decreased as a function of the dose in the red channel. For a dose range of 0 to 50 cGy, the total uncertainties for 5, 10, and 50 cGy were 14.2%, 8.9%, and 5%, respectively. Quantitative evaluation using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) method presented no cytotoxicity. Further, no corneal opacity, iris reaction, or conjunctival inflammation was observed.
CONCLUSIONS: The CLOD is the first dosimeter that can be worn close to the eye. The results of cytotoxicity and irritation tests indicate that it is a stable medical device. The evaluation of dose characteristics in open field conditions shows that the CLOD can be applied to an in vivo dosimeter in radiotherapy.

Cataracts are the leading cause of blindness and visual disability worldwide. Of the known contributing factors to this condition, ionising radiation is considered the primary concern in a radiological context given the particular radiosensitivity of the lens of the eye. In light of the substantially increased application of computed tomography in brain imaging, an investigation of the relevent literature is warranted to assess thresholds, lens radiation doses and dose reduction techniques in respect to the cataractogenic risk of such examinations. The value and very existence of a lens dose threshold is debatable given different considerations of radiation dose, latency, opacity classifications and historical sample populations, though ICRP guidelines suggest a threshold of 0.5 Gy. Documented CT-specific radiation doses to the eye following scans of the brain are highly variable between studies (2-130 mGy), primarily owing to discrepancies in scanning technique. These findings, when coupled with the relative ambiguity of known threshold values, present difficulties in assessing the overall risk of cataracts following serial CT examinations to the head. In the absence of definitive risk evaluations, a cautionary approach is advised. The implementation of gantry tilt along the supraorbital margin is recommended as standard practice on account of its highly effective radiation dose reduction outcomes. Organ-based tube modulation and reductions in tube current may also be considered beneficial. Bismuth eye shielding is only advised where gantry tilting is unachievable, and in such cases, ensure careful adherence to appropriate shield placement and infection control measures.

UNASSIGNED: The aim was to measure doses of eyes and lenses in the presence and absence of shield during whole brain irradiation (WBI). In addition, the dose calculations accuracy of radiation therapy dose plan treatment planning system (TPS) in dose calculation of the eyes and lenses in WBI was evaluated.
UNASSIGNED: To measure the eyes and lenses doses during WBI, an inhomogeneous phantom of human head was used. Then, the eyes and lenses doses in the presence and absence of shield were measured by EBT3 film.
UNASSIGNED: In single fraction with 200 cGy to reference point, average doses received by the left and right eyes in the absence of shield were 20 ± 1.5 and 22 ± 1.0 cGy, respectively, and for the left and right eyes in the presence of shield were 18 ± 2.2 and 21 ± 2 cGy, respectively. In addition, the average dose received by the left and right lenses in the absence of shield were 19.5 ± 0.5 and 18.5 ± 0.5 cGy, respectively, and for the left and right lenses in the presence of shield were 20.5 ± 1.5 and 19.5 ± 1.5 cGy, respectively. The results showed the TPS compared to the film underestimates doses for the eyes and lenses.
UNASSIGNED: The average dose received by the eyes and lenses during WBI were estimated around 9-11% of prescribed dose. According to the results, there is probability of radiation-induced cataractogenesis during WBI. By investigating the effect of shield on the lenses and eyes doses, using shield during WBI is not recommended. In addition, the results showed dose calculation accuracy of the TPS for the estimation of doses received by the eyes and lenses during WBI is not acceptable.